Technology And Equipment Tenders

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Filgrastim (Atc Code According to Who: L03aa02)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V by Means of a So-Called Open House Model for Medicines with the Trade Name Acarizax(R) (Atc Code According to Who: V01aa03)

Grad. not Excluding am Discount Agreement. According to § 130A Para. 8 Sgb V by Means of an Oh Model to the Ws Epoetin Alfa (Genetically Engineered Human Erythropoietin - Restriction on Pack with Dosage up to 10,000 Iu)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ebastine with an Effective Strength of 20 Mg and the Dosage Form Smt

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Baclofen in the Dosage Form Inf

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Acarbose - not in Standard Size 2

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Acetylcysteine ​​In the Dosage Form Lse

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Acetylcysteine ​​As an Otc Medicinal Product

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V on Active Ingredients (Medicines) - Vv_77

Open House Contracts 2024-2